Wendy Walsh

Randomized Phase II Study Comparing Two Schedules of Everolimus in Patients With Recurrent/Metastatic Breast Cancer: NCIC Clinical Trials Group IND.163

Susan Ellard, Mark Clemons, Karen A. Gelmon et al. · Journal of Clinical Oncology · 2009 · 261 citations

Medicine, Oncology, Pharmacology +16

Gemcitabine Plus Cisplatin, an Active Regimen in Advanced Urothelial Cancer: A Phase II Trial of the National Cancer Institute of Canada Clinical Trials Group

Malcolm J. Moore, Eric Winquist, Nevin Murray et al. · Journal of Clinical Oncology · 1999 · 230 citations

Medicine, Oncology, Pharmacology +16

Bortezomib Is Active in Patients With Untreated or Relapsed Waldenström's Macroglobulinemia: A Phase II Study of the National Cancer Institute of Canada Clinical Trials Group

Christine I. Chen, C. Tom Kouroukis, Darrell White et al. · Journal of Clinical Oncology · 2007 · 189 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Interleukin-21 Has Activity in Patients With Metastatic Melanoma: A Phase II Study

Teresa M. Petrella, Richard Tozer, Karl Bélanger et al. · Journal of Clinical Oncology · 2012 · 124 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase I and Pharmacokinetic Study of Daily Oral AZD2171, an Inhibitor of Vascular Endothelial Growth Factor Tyrosine Kinases, in Combination With Carboplatin and Paclitaxel in Patients With Advanced Non–Small-Cell Lung Cancer: The National Cancer Institute of Canada Clinical Trials Group

Scott A. Laurie, Isabelle Gauthier, Andrew Arnold et al. · Journal of Clinical Oncology · 2008 · 120 citations

Medicine, Pharmacokinetics, Pharmacology +17